5ZBO

Cryo-EM structure of PCV2 VLPs

Summary for 5ZBO

• Entry DOI: 10.2210/pdb5zbo/pdb
• EMDB information: 6746
• Descriptor: Capsid protein (1 entity in total)
• Functional Keywords: porcine circle virus type 2 (pcv2), capsid protein, virus-like-particle (vlp), type-specific epitope, dna binding protein
• Biological source: Porcine circovirus 2 (PCV2)
• Total number of polymer chains: 60
• Total formula weight: 1447563.06

Authors

Mo, X.,Yuan, A.Y. (deposition date: 2018-02-12, release date: 2019-02-20, Last modification date: 2024-03-27)

Primary citation

Mo, X.,Li, X.,Yin, B.,Deng, J.,Tian, K.,Yuan, A.
Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope.
PLoS Pathog., 15:e1007562-e1007562, 2019

PubMed Abstract: Postweaning multisystemic wasting disease (PMWS) in piglets caused by porcine circovirus type 2 (PCV2) is one of the major threats to most pig farms worldwide. Among all the PCV types, PCV2 is the dominant genotype causing PMWS and associated diseases. Considerable efforts were made to study the virus-like-particle (VLP) assembly and the specific PCV2-associated epitope(s) in order to establish the solid foundation for engineered PCV2 vaccine development. Although the N-terminal fragment including Nuclear Localization Signal (NLS) sequence seems important for recombinant PCV2 capsid protein expression and VLP assembly, the detailed structural and functional information regarding this important fragment are largely unknown. In this study, we report crystal structure of PCV2 VLP assembled from N-terminal NLS truncated PCV2 capsid protein at 2.8 Å resolution and cryo-EM structure of PCV2 VLP assembled from full-length PCV2 capsid protein at 4.1Å resolution. Our in vitro PCV2 VLP assembly results show that NLS-truncated PCV2 capsid protein only forms instable VLPs which were easily disassembled in solution, whereas full-length PCV2 capsid protein forms stable VLPs due to interaction between 15PRSHLGQILRRRP27 (α-helix) and 33RHRYRWRRKN42 (NLS-B) in a repeated manner. In addition, our results also showed that N-terminal truncation of PCV2 capsid protein up to 27 residues still forms PCV2 particles in solution with similar size and immunogenicity, while N-terminal truncation of PCV2 capsid protein with more than 30 residues is not able to form stable PCV2 particles in solution, demonstrating the importance of interaction between the α-helix at N-terminal and NLS-B in PCV2 VLP formation. Moreover, we also report the cryo-EM structure of PCV2 VLP in complex with 3H11-Fab, a PCV2 type-specific neutralizing antibody, at 15 Å resolution. MAb-3H11 specifically recognizes one exposed epitope located on the VLP surface EF-loop (residues 128-143), which is further confirmed by PCV1-PCV2 epitope swapping assay. Hence, our results have revealed the structural roles of N-terminal fragment of PCV2 capsid protein in PCV2 particle assembly and pinpointed one PCV2 type-specific neutralizing epitope for the first time, which could provide clear clue for next generation PCV2 vaccine and diagnostic kits development.

PubMed: 30822338
DOI: 10.1371/journal.ppat.1007562

Experimental method

ELECTRON MICROSCOPY (4.12 Å)